E
Portage Biotech Inc. PRTG
$8.26 -$0.99-10.70%
Recommendation
Sell
Prev Close
$9.60
Volume
272,784
Avg Vol (90D)
834,790
Market Cap
$15.80M
Dividend & Yield
--
52-Week Range
$2.10 - $23.01
P/E (TTM)
--
EPS (TTM)
-$64.28
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Portage Biotech trading resumes
3/31/2025 - The Fly
Portage Biotech trading halted, volatility trading pause
3/31/2025 - TipRanks Financial Blog
Portage Biotech trading halted, volatility trading pause
3/31/2025 - The Fly
Small Cap Stocks To Add to Your Watchlist - March 29th
3/30/2025 - MarketBeat
Portage Biotech Insider Buyers See Boost After Market Cap Rose US$9.0m
3/30/2025 - Simply Wall St
Promising Biotech Stocks To Watch Now - March 28th
3/28/2025 - MarketBeat
Why Is Portage Biotech Stock Skyrocketing Friday?
3/28/2025 - Benzinga
Portage Biotech's After-Hours Surge On Preclinical Tumor Trial Data Sends Retail Optimism Sky-High
3/28/2025 - Stocktwits News Feed
Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human ...
3/27/2025 - GuruFocus
Portage Biotech presents preclinical data for PORT-7
3/27/2025 - The Fly
Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7
3/27/2025 - Globe Newswire
Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial
3/12/2025 - GuruFocus
Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial
3/12/2025 - Globe Newswire
Portage Biotech Inc. (NASDAQ:PRTG) Sees Large Decline in Short Interest
3/2/2025 - Ticker Report
Portage Biotech Inc. (NASDAQ:PRTG) Short Interest Up 15.2% in January
2/17/2025 - Ticker Report
Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued ...
2/12/2025 - GuruFocus
Portage Biotech receives extension from Nasdaq to attain listing compliance
2/12/2025 - Seeking Alpha - Healthcare
Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
2/12/2025 - Globe Newswire
Portage Biotech Inc. (NASDAQ:PRTG) Sees Large Decline in Short Interest
1/31/2025 - Ticker Report
Portage Biotech Secures $2.15 Million in Private Financing
1/30/2025 - TipRanks Financial Blog
Portage Biotech Announces Completion of $2.15 Million Private Financing
1/30/2025 - GuruFocus
Portage Biotech Announces Completion of $2.15 Million Private Financing
1/30/2025 - Globe Newswire
Portage Biotech (NASDAQ:PRTG) Shares Down 7.2% - What's Next?
1/11/2025 - Ticker Report
Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; ...
1/6/2025 - GuruFocus
Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; ...
1/6/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$11.72M
EBIT (TTM)
-$11.76M
Net Income (TTM)
-$67.28M
Balance Sheet
Total Assets (Q)
$2.71M
Total Debt (Q)
$28.00K
Total Liabilities (Q)
$2.01M
Book Value Per Share (Q)
$1.25
Cash Flow
Cash from Operations (TTM)
-$9.80M
Cash from Investing (TTM)
$2.81M
Cash from Financing (TTM)
$5.31M
Net Change in Cash (TTM)
-$1.68M
Filings
Filing Date
Tuesday, November 26, 2024
Period Date
Monday, September 30, 2024
Next Filing
(est)
Price History
Loading...
Beta
1.60
7-Day Total Return
89.89%
30-Day Total Return
75.61%
60-Day Total Return
59.77%
90-Day Total Return
101.96%
Year to Date Total Return
69.26%
1-Year Total Return
-25.32%
2-Year Total Return
-84.59%
3-Year Total Return
-93.99%
5-Year Total Return
-95.41%
52-week Low
Aug 14, 2024 - $2.10
52-week High
Sep 18, 2024 - $23.01
Valuation
Market Cap
$15.80M - Nano Cap
Enterprise Value
$13.36M
Price/Sales (TTM)
--
Price/Book (Q)
7.67
Dividends and Shares
Shares Outstanding
1.08M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.portagebiotech.com
Phone Number
203 221 7378
Address
Clarence Thomas Building
P.O. Box 4649 - Road Town
Tortola, VG1110
Country
British Virgin Islands
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual... more
NASDAQ 04/01/2025 4:00PM Eastern Quotes delayed
Weiss Ratings